This course covers recent advancements in the treatment of blood cancers. The learning outcomes include understanding how blood cancers develop, the balance in cells and genes, the role of oncogenes, and the development of blood cells. Students will learn about blood testing, cell death, toxicity of treatments, and targeting strategies such as Rituxan, specific antibodies, targeted chemotherapy, and CAR T-cell therapy. The teaching method includes lectures and discussions. The intended audience for this course includes healthcare professionals, researchers, medical students, and individuals interested in the latest treatments for blood cancers.
Advancements in the Treatment of Blood Cancers - Closer to a Cure Series
University of California, Los Angeles via YouTube
Overview
Syllabus
Introduction
About the Leukemia Lymphoma Society
Information Specialists
Clinical Trial Support Center
Pearl Point Nutrition Referral
Financial Assistance
Peer Community Support
Cancer Support Communities
Leukemia Society Mission
Volunteer Opportunities
Conclusion
Questions
How do Blood Cancers Develop
Balance in the Cells
Balance in the Genes
Oncogenes
Multiple genes
Terminology
Development of Blood Cells
Blood Testing
Cell Death
Toxicity of Treatments
Targeting
Rituxan
By Specific Antibodies
Targeted Chemotherapy
CAR Tcell Arena
BTK Signaling
Taught by
UCLA Health
